NCT07440667

Brief Summary

Spinal anesthesia for elective cesarean section is frequently associated with hemodynamic instability and postoperative complications such as postoperative nausea and vomiting (PONV) and delayed gastrointestinal recovery. Although intraoperative fluid administration is routinely used to prevent spinal-induced hypotension, the optimal fluid strategy remains unclear. Both restrictive and liberal fluid approaches may influence maternal hemodynamics and postoperative outcomes through different physiological mechanisms. This prospective, single-center, randomized controlled trial aims to compare restrictive (≤3 mL/kg/h) and liberal (\>3 mL/kg/h) intraoperative crystalloid fluid strategies in patients undergoing elective cesarean section under spinal anesthesia. The primary outcome is the incidence of PONV within the first 24 hours postoperatively. Secondary outcomes include postdural puncture headache (PDPH), time to first flatus, hypotension frequency, and vasopressor requirements.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
160

participants targeted

Target at P75+ for not_applicable

Timeline
8mo left

Started Mar 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress24%
Mar 2026Jan 2027

First Submitted

Initial submission to the registry

February 23, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
5 days until next milestone

Study Start

First participant enrolled

March 4, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2027

Last Updated

March 10, 2026

Status Verified

March 1, 2026

Enrollment Period

11 months

First QC Date

February 23, 2026

Last Update Submit

March 7, 2026

Conditions

Keywords

Cesarean SectionSpinal AnesthesiaIntraoperative Fluid TherapyRestrictive Fluid StrategyLiberal Fluid StrategyPostoperative Nausea and VomitingPostdural Puncture HeadacheGastrointestinal RecoveryHypotensionVasopressor Use

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative nausea and vomiting (PONV)

    Occurrence of nausea and/or vomiting within the first 24 hours after surgery, recorded as present or absent.

    0-24 hours postoperatively

Secondary Outcomes (4)

  • Incidence and severity of postdural puncture headache (PDPH)

    24-72 hours postoperatively

  • Time to first flatus

    Up to 72 hours postoperatively

  • Frequency of intraoperative hypotension

    Intraoperative period

  • Total intraoperative vasopressor dose

    Intraoperative period

Study Arms (2)

Restrictive intraoperative fluid strategy (≤3 mL/kg/h)

EXPERIMENTAL

Participants undergoing elective cesarean section under spinal anesthesia will receive intraoperative crystalloid at a target average infusion rate of ≤3 mL/kg/h. Standardized spinal anesthesia technique and intraoperative management will be applied. Hypotension will be treated according to the predefined rescue protocol (e.g., ephedrine and/or additional fluid bolus as clinically indicated).

Other: Restrictive intraoperative crystalloid fluid strategy (≤3 mL/kg/h)

Liberal intraoperative fluid strategy (>3 mL/kg/h)

ACTIVE COMPARATOR

Participants undergoing elective cesarean section under spinal anesthesia will receive intraoperative crystalloid at a target average infusion rate of \>3 mL/kg/h. Standardized spinal anesthesia technique and intraoperative management will be applied. Hypotension will be treated according to the predefined rescue protocol (e.g., ephedrine and/or additional fluid bolus as clinically indicated).

Other: Liberal intraoperative crystalloid fluid strategy (>3 mL/kg/h)

Interventions

Intraoperative crystalloid administration targeting an average rate of ≤3 mL/kg/h during elective cesarean section under spinal anesthesia.

Restrictive intraoperative fluid strategy (≤3 mL/kg/h)

Intraoperative crystalloid administration targeting an average rate of \>3 mL/kg/h during elective cesarean section under spinal anesthesia.

Liberal intraoperative fluid strategy (>3 mL/kg/h)

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Female patients aged 18-45 years
  • ASA physical status II
  • Scheduled for elective cesarean section under spinal anesthesia
  • Provision of written informed consent

You may not qualify if:

  • Emergency cesarean section
  • Preeclampsia or eclampsia
  • Known cardiac failure
  • Known renal failure
  • Known hepatic failure
  • Coagulopathy
  • Contraindication to spinal anesthesia
  • Conversion to general anesthesia
  • Major technical complications during spinal anesthesia
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Niğde Ömer Halisdemir University Hospital

Niğde, Merkez, 51240, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Postoperative Nausea and VomitingPost-Dural Puncture HeadacheHypotension

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsNauseaSigns and Symptoms, DigestiveSigns and SymptomsVomitingHeadache Disorders, SecondaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Pınar Erdoğan, Assoc Prof

    Niğde Ömer Halisdemir University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pınar Erdoğan, Assoc. Prof.

CONTACT

Seval Kılbasanlı, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will be blinded to group allocation. The anesthesia team will not be blinded due to the nature of the intervention (intraoperative fluid strategy). Postoperative outcomes will be collected by a blinded assessor who is not involved in intraoperative care and has no access to allocation information. Group allocation will be recorded in a separate study log and concealed from participants and outcome assessors until completion of follow-up.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomized in a 1:1 ratio to one of two parallel groups receiving either a restrictive (≤3 mL/kg/h) or a liberal (\>3 mL/kg/h) intraoperative crystalloid fluid strategy during elective cesarean section under spinal anesthesia. Each participant is assigned to a single intervention arm and followed for postoperative outcomes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

February 23, 2026

First Posted

February 27, 2026

Study Start

March 4, 2026

Primary Completion (Estimated)

January 30, 2027

Study Completion (Estimated)

January 30, 2027

Last Updated

March 10, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be publicly shared due to institutional policies and ethical considerations related to patient confidentiality. De-identified data may be made available upon reasonable request to the corresponding investigator, subject to approval by the institutional ethics committee and data protection regulations.

Locations